Lung Cancer Driven by BRAFG469V Mutation Is Targetable by EGFR Kinase Inhibitors.
Huo KG, Notsuda H, Fang Z, Liu NF, Gebregiworgis T, Li Q, Pham NA, Li M, Liu N, Shepherd FA, Marshall CB, Ikura M, Moghal N, Tsao MS.
Huo KG, et al. Among authors: li m, li q.
J Thorac Oncol. 2022 Feb;17(2):277-288. doi: 10.1016/j.jtho.2021.09.008. Epub 2021 Oct 12.
J Thorac Oncol. 2022.
PMID: 34648945
Free article.